Abundant empty class II MHC molecules on the surface of immature dendritic cells.

A monoclonal antibody specific for the empty conformation of class II MHC molecules revealed the presence of abundant empty molecules on the surface of spleen- and bone marrow-derived dendritic cells (DC) among various types of antigen-presenting cells. The empty class II MHC molecules are developmentally regulated and expressed predominantly on immature DC. They can capture peptide antigens directly from the extracellular medium and present bound peptides to antigen-specific T lymphocytes. The ability of the empty cell-surface class II MHC proteins to bind peptides and present them to T cells without intracellular processing can serve to extend the spectrum of antigens able to be presented by DC, consistent with their role as sentinels in the immune system.

[1]  R. Germain,et al.  MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding , 1991, Nature.

[2]  R. Germain,et al.  Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP) , 1996, The Journal of experimental medicine.

[3]  R. Flavell,et al.  Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. , 1996, Immunity.

[4]  J. Rothbard,et al.  Detection of peptide-MHC class II complexes on the surface of intact cells. , 1990, Journal of immunological methods.

[5]  D. Weber,et al.  Inefficient peptide binding by cell-surface class II MHC molecules. , 1997, Cellular immunology.

[6]  P. Cresswell,et al.  HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading , 1995, Cell.

[7]  J. Salamero,et al.  Mouse B lymphocyte specific endocytosis and recycling of MHC class II molecules. , 1990, The EMBO journal.

[8]  R. Germain,et al.  Related Leucine-based Cytoplasmic Targeting Signals in Invariant Chain and Major Histocompatibility Complex Class II Molecules Control Endocytic Presentation of Distinct Determinants in a Single Protein , 1997, The Journal of experimental medicine.

[9]  M. Lotze,et al.  Rapid extracellular degradation of synthetic class I peptides by human dendritic cells. , 1998, Journal of immunology.

[10]  J. Salamero,et al.  Intracellular pathway for the generation of functional MHC class II peptide complexes in immature human dendritic cells. , 1998, Journal of immunology.

[11]  J. Coligan,et al.  Large protein fragments as substrates for endocytic antigen capture by MHC class II molecules. , 1998, Journal of immunology.

[12]  G. B. Wisdom,et al.  Current protocols in immunology , 1993 .

[13]  A. Sette,et al.  Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. , 1996, Journal of immunology.

[14]  C. Benoist,et al.  Mice lacking the MHC class II-associated invariant chain , 1993, Cell.

[15]  Eric O Long,et al.  Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. A. Peterson,et al.  Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. , 1998, Immunity.

[17]  D. Wiley,et al.  The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide , 1992, Cell.

[18]  J. Tschopp,et al.  Murine Thy-1+ dendritic epidermal T cell lines express granule-associated perforin and a family of granzyme molecules. , 1992, Immunobiology.

[19]  K. Carlsson,et al.  HLA-DM is expressed on the cell surface and colocalizes with HLA-DR and invariant chain in human Langerhans cell , 1998, Archives of Dermatological Research.

[20]  C. Benoist,et al.  Mice lacking the transcription factor CIITA--a second look. , 1998, International immunology.

[21]  R. Germain,et al.  Processing and Presentation of Endocytically Acquired Protein Antigens by MHC Class II and Class I Molecules , 1996, Immunological reviews.

[22]  Francesca Granucci,et al.  Maturation Stages of Mouse Dendritic Cells in Growth Factor–dependent Long-Term Cultures , 1997, The Journal of experimental medicine.

[23]  P. Ricciardi-Castagnoli,et al.  Dendritic cell maturation and antigen presentation in the absence of invariant chain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Steinman,et al.  The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies , 1990, The Journal of experimental medicine.

[25]  J. Altman,et al.  Stability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: comparison to class I proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Germain,et al.  Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules , 1993, Nature.

[27]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[28]  W A Hendrickson,et al.  Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. , 1998, Immunity.

[29]  M. Jackson,et al.  Empty and peptide-containing conformers of class I major histocompatibility complex molecules expressed in Drosophila melanogaster cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[30]  F. Young.  Biochemistry , 1955, The Indian Medical Gazette.

[31]  J. Pieters,et al.  The MHC class II-associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail. , 1993, Journal of cell science.

[32]  M. Davis,et al.  Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH , 1991, The Journal of experimental medicine.

[33]  C. Watts,et al.  Capture and processing of exogenous antigens for presentation on MHC molecules. , 1997, Annual review of immunology.

[34]  L. Stern,et al.  Empty and peptide-loaded class II major histocompatibility complex proteins produced by expression in Escherichia coli and folding in vitro. , 1999, Protein expression and purification.

[35]  J. Rothbard,et al.  T cell specificity for class II (I-A) and the encephalitogenic N-terminal epitope of the autoantigen myelin basic protein. , 1987, Journal of immunology.

[36]  R. Steinman,et al.  The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing , 1995, Nature.

[37]  D. Gray,et al.  Mice lacking MHC class II molecules , 1991, Cell.

[38]  R. Steinman,et al.  Developmental regulation of MHC class II transport in mouse dendritic cells , 1997, Nature.

[39]  R. Germain,et al.  Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression , 1993, The Journal of experimental medicine.

[40]  P. Ricciardi-Castagnoli,et al.  A newly identified antigen retention compartment in the FSDC precursor dendritic cell line. , 1997, Advances in experimental medicine and biology.

[41]  D. Wiley,et al.  Structural characterization of a soluble and partially folded class I major histocompatibility heavy chain/β2m heterodimer , 1998, Nature Structural Biology.

[42]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[43]  J. Frelinger,et al.  Production and characterization of two new mouse monoclonal antibodies reactive with denatured mouse class II beta chains. , 1992, Hybridoma.

[44]  R. Sobel,et al.  Altered peptide ligand modulation of experimental allergic encephalomyelitis: immune responses within the CNS , 1998, Journal of Neuroimmunology.

[45]  C Danieli,et al.  Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , 1995, The Journal of experimental medicine.

[46]  K. Rajewsky,et al.  Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice. , 1998, Immunity.

[47]  K. A. Wall,et al.  A disease-related epitope of Torpedo acetylcholine receptor. Residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism. , 1994, Journal of immunology.

[48]  E. Unanue,et al.  Processing of lysozyme by macrophages: identification of the determinant recognized by two T-cell hybridomas. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[49]  P. Bjorkman,et al.  Thermal stability comparison of purified empty and peptide-filled forms of a class I MHC molecule. , 1992, Science.

[50]  L Adorini,et al.  Capacity of intact proteins to bind to MHC class II molecules. , 1989, Journal of immunology.

[51]  Antonio Lanzavecchia,et al.  Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells , 1997, Nature.

[52]  L. Herzenberg,et al.  Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. , 1978, Current topics in microbiology and immunology.

[53]  R. Mitchell,et al.  Cathepsin S activity regulates antigen presentation and immunity. , 1998, The Journal of clinical investigation.

[54]  B. Mach,et al.  Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA , 1997, The EMBO journal.

[55]  H. Ploegh,et al.  DM exchange mechanism , 1995, Nature.

[56]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.

[57]  C. Benoist,et al.  I-A alpha polymorphic residues that determine alloreactive T cell recognition , 1989, The Journal of experimental medicine.

[58]  E. Coligan.  Current protocols in immunology , 1991 .

[59]  J. Strominger,et al.  Extracellular antigen processing and presentation by immature dendritic cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[60]  G. Benedek,et al.  A conformational change in the human major histocompatibility complex protein HLA-DR1 induced by peptide binding. , 1999, Biochemistry.

[61]  M. Vrljic,et al.  Formation of a highly peptide-receptive state of class II MHC. , 1998, Immunity.

[62]  Ronald N. Germain,et al.  MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation , 1994, Cell.

[63]  Alan F. Williams,et al.  Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus , 1982, European journal of immunology.

[64]  Eric O Long,et al.  Peptide loading onto recycling HLA‐DR molecules occurs in early endosomes , 1998, European journal of immunology.

[65]  H. Ploegh,et al.  How MHC class II molecules reach the endocytic pathway. , 1995, The EMBO journal.

[66]  Mark M. Davis,et al.  Ligand-specific oligomerization of T-cell receptor molecules , 1997, Nature.